E-prescriptions, triptans and COVID-19 vaccines: your questions answered
In this monthly series, Australian Pharmacist speaks to the experts to answer some of your most frequently asked questions.
Expect an increase in demand for long-acting injectable buprenorphine
Changes to the Opioid Dependence Treatment program could make long-acting injectable buprenorphine the best option for many people.
Changes to PBS antibiotic prescribing
In a move aimed at reducing antibiotic resistance, the Pharmaceutical Benefits Advisory Committee (PBAC) has recommended that four of the most widely prescribed antibiotics...
TGA approves Pfizer booster for teens
Pfizer’s Comirnaty COVID-19 vaccine has been provisionally approved by the Therapeutic Goods Administration (TGA) for use as a booster in those aged 16–17 years.
Therapeutic contact lenses: the future of drug delivery?
A novel therapy under investigation could see pharmacists playing a greater role in helping patients to manage some common eye conditions.
Meet the newest members of PSA’s leadership team
The results of PSA’s Branch elections are in, with three innovative new leaders chosen to steer the profession through challenging times.
